[Intracerebral penetration of harmaline].
D000470:Alkaloids / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology; D000818:Animals; D002552:Cerebral Ventricles / Q000033:anatomy & histology*; D004058:Diffusion; D007211:Indoles / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology; D007267:Injections; D007274:Injections, Intraperitoneal; D008856:Microscopy, Fluorescence; D008996:Monoamine Oxidase Inhibitors / Q000008:administration & dosage / Q000378:metabolism* / Q000494:pharmacology; D009474:Neurons / Q000378:metabolism*; D010863:Piloerection; D010946:Plants, Medicinal / Q000032:analysis; D011725:Pyridines / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology; D012639:Seeds; D013997:Time Factors
D000470:Alkaloids; D007211:Indoles; D008996:Monoamine Oxidase Inhibitors; D011725:Pyridines
Pénétration intracérbrale de l'harmaline